Oral Drug S-1 Linked to Longer Survival Than Capecitabine in Metastatic Breast Cancer Study
A retrospective cohort study of 123 patients suggests the oral fluoropyrimidine S-1 may deliver longer overall survival than capecitabine as ...
A retrospective cohort study of 123 patients suggests the oral fluoropyrimidine S-1 may deliver longer overall survival than capecitabine as ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.